Press release

  • Provepharm announces impressive trading and financial results for 2011
    PDF - 125.7 ko
    PR 2012 February 16th

     
     
     
     

  • Provepharm signs license agreement with Daiichi Sankyo to provide “Methylthioninium chloride Proveblue, Solution for injection” to Japan
    PDF - 141.3 ko
    PR 2011 November 29th

     
     
     
     

  • Martindale Pharma® and Provepharm partner to provide “Methylthioninium chloride Proveblue solution for injection” to the UK and Ireland
    PDF - 89.9 ko
    PR 2011 November 28th

     
     
     
     
     

  • Provepharm obtains European marketing authorization for its Methylthioninium Chloride Proveblue
    PDF - 92.6 ko
    PR 2011 May 24th

     
     
     
     
     

  • Provepharm Receives Favorable EMA Review of its Methylthioninium Chloride Proveblue
    PDF - 220.6 ko
    PR 2011 March 11th

     
     
     
     
     

  • Provepharm announces acceptance of Proveblue® injectable drug MAA for review under EMEA centralized procedure and validation by Novasep of API cGMP process
    PDF - 236.1 ko
    PR 2010 February 11th